PMV Pharmaceuticals, Inc.
USD1.31
+0.03 (+2.34%)
CEO
David H. Mack
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.30
Prev. Close
$1.28
Day Low
$1.29
Day High
$1.32
52W Low
$1.02
52W High
$1.88
Market Cap
$0.07B
Volume
0.07M
| 42,000 |
| $1.19 |
| 5 Jun 2026 | Gallagher Carol Giltner | director | A-Award | Acquired | 42,000 | $1.19 |
| 5 Jun 2026 | Gallagher Carol Giltner | director | G-Gift | Disposed | 42,000 | $1.19 |
| 5 Jun 2026 | Gallagher Carol Giltner | director | G-Gift | Acquired | 42,000 | $1.19 |
| 5 Jun 2026 | FLOWERS KIRSTEN | director | A-Award | Acquired | 42,000 | $1.19 |
| 5 Jun 2026 | BAUM CHARLES M | director | A-Award | Acquired | 42,000 | $1.19 |
| 9 Mar 2026 | Carulli Michael | Chief Financial Officer | A-Award | Acquired | 240,000 | $1.53 |
| 9 Mar 2026 | Ticktin Robert | General Counsel & COO | A-Award | Acquired | 319,270 | $1.53 |
| 9 Mar 2026 | Jalota Deepika | Chief Development Officer | A-Award | Acquired | 303,310 | $1.53 |